Moore Capital Management’s DexCom DXCM Stock Holding History

Moore Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,914	Closed	-$2.21M	–	714
2025 Q3	$2.21M	Buy	+32,914	New	+$2.6M	0.03%	347
2024 Q1	–	Sell	-30,000	Closed	-$3.72M	–	470
2023 Q4	$3.72M	Buy	+30,000	New	+$3.06M	0.06%	185
2023 Q3	–	Sell	-15,000	Closed	-$1.93M	–	524
2023 Q2	$1.93M	Sell	15,000 -122,547	-89%	-$14.8M	0.03%	260
2023 Q1	$16M	Buy	137,547 +77,547	+129%	+$8.68M	0.34%	58
2022 Q4	$6.79M	Sell	60,000 -29,979	-33%	-$3.29M	0.16%	120
2022 Q3	$7.25M	Buy	+89,979	New	+$7.62M	0.17%	129
2022 Q2	–	Sell	-55,396	Closed	-$7.08M	–	720
2022 Q1	$7.08M	Sell	55,396 -174,040	-76%	-$19M	0.18%	130
2021 Q4	$30.8M	Buy	+229,436	New	+$33M	0.61%	28
2021 Q3	–	Sell	-194,852	Closed	-$20.8M	–	816
2021 Q2	$20.8M	Sell	194,852 -52,440	-21%	-$5.04M	0.3%	74
2021 Q1	$22.2M	Buy	+247,292	New	+$23.2M	0.28%	66

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Moore Capital Management's DXCM Position: Q4 2025 in Review

Moore Capital Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 32,914 shares — an estimated $2.21M sold.

Moore Capital Management first reported a position in DXCM in Q1 2021 and held it in 10 quarters. The position peaked at $30.8M in Q4 2021. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Moore Capital Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Moore Capital Management sold 32,914 DexCom shares in Q4 2025, an estimated $2.21M.
Moore Capital Management first reported a position in DexCom in Q1 2021 and held it in 10 quarters.
Moore Capital Management's DexCom position peaked at $30.8M in Q4 2021.
920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Moore Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.